Karis Teetan

Ask VT AI
View News Summary
  • Debate erupts over Quail Hollow's character ahead of 2025 PGA Championship, with some criticizing course changes and others defending its challenging layout.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • American Eagle reports $85M loss, withdraws guidance amid economic uncertainty.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Debate erupts over Quail Hollow's character ahead of 2025 PGA Championship, with some criticizing course changes and others defending its challenging layout.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
  • American Eagle reports $85M loss, withdraws guidance amid economic uncertainty.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Karis Teetan